Skip to main content
Equibles
LH logo

LH · Labcorp Holdings Inc. · Metrics

Track LH — free

Use LH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$323.82 +0.69 (+0.21%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$26.21B
Shares
81.10M
Volume · Oct 21 51.45K Avg daily vol (3M) 733.88K

LH metrics

115 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$323.13
Market cap
$26.21B

Price action

20 metrics
Price change (1W)
+3.0%
Price change (30D)
+0.7%
Price change (3M)
+15.7%
Price change (6M)
+18.2%
Price change (YTD)
+28.8%
Price change (1Y)
+11.1%
Trailing year
Price change (5Y)
—
52-week high
$339.34
52-week low
$246.64
Change from 52-week high
-4.8%
Change from 52-week low
+31.0%
Annualized volatility
24.1%
Annualized volatility (3M)
24.1%
Beta
0.3
RSI (14D)
58.2
Price vs SMA 50
+0.8%
Price vs SMA 200
+13.7%
Avg volume (3M)
733,880
Relative volume
0.8
Average dollar volume
$231.49M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
81.10M

Valuation

12 metrics
P / E (TTM)
26.7
Trailing earnings · reciprocal yield 3.7%
PEG ratio
0.9
EV / revenue
2.2×
reciprocal yield 45.4%
EV / EBITDA
14.4×
reciprocal yield 6.9%
EV / EBIT
21.1×
reciprocal yield 4.7%
P / sales
1.8×
reciprocal yield 55.5%
P / book
3.0
reciprocal yield 33.3%
FCF yield
4.5%
TTM · current market cap
Buyback yield
2.7%
P / FCF
22.4
reciprocal yield 4.5%
P / operating cash flow
15.8
reciprocal yield 6.3%
Earnings yield
3.9%

Historical valuation

8 metrics
P / E historical average (3Y)
26.6×
reciprocal yield 3.8%
P / E historical average (5Y)
19.4×
reciprocal yield 5.1%
EV / revenue historical average (3Y)
2.0×
reciprocal yield 50.3%
EV / revenue historical average (5Y)
1.9×
reciprocal yield 51.7%
EV / EBIT historical average (3Y)
23.0×
reciprocal yield 4.4%
EV / EBIT historical average (5Y)
19.8×
reciprocal yield 5.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.9%
Trailing 12 months
Payout ratio
23.9%
Shareholder yield
3.6%
Dividend / share (TTM)
$2.88
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-08-28

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
28.9%
Operating margin
10.4%
Trailing 12 months
Net margin
7.0%
Gross profit (TTM)
$4.14B
Operating profit (TTM)
$1.50B
Net income (TTM)
$1.00B
Trailing 12 months
Diluted EPS (TTM)
$12.09
FCF margin
8.1%
Effective tax rate
18.7%

Per share

11 metrics
Revenue per diluted share (TTM)
$172.95
Gross profit per diluted share (TTM)
$49.96
Operating profit per diluted share (TTM)
$18.05
EBITDA per diluted share (TTM)
$26.44
Net income per diluted share (TTM)
$12.09
Operating cash flow per diluted share (TTM)
$19.74
Free cash flow per diluted share (TTM)
$13.91
Capital expenditures per diluted share (TTM)
$5.83
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.51
Book value per share
$104.86

Growth

11 metrics
Revenue growth YoY
+5.8%
Year over year
Net income growth YoY
+25.6%
Revenue (TTM)
$14.35B
Trailing 12 months
EPS growth YoY
+28.2%
Shares change YoY
-2.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.6%
Revenue CAGR (5Y)
0.0%
EPS CAGR (3Y)
-9.2%
EPS CAGR (5Y)
-8.0%
FCF CAGR (3Y)
-7.6%
FCF CAGR (5Y)
-7.2%

Quality

14 metrics
Return on equity
11.6%
Return on assets
5.4%
Debt / equity
0.7
Current ratio
1.8
EBITDA (TTM)
$2.19B
Free cash flow (TTM)
$1.16B
Quick ratio
1.5
Interest coverage
6.6
Net debt / EBITDA
2.6
Return on invested capital
8.5%
Trailing 12 months
Net cash
−$5.72B
Latest balance sheet
Cash & equivalents
$141.80M
Total assets
$18.53B
Total debt
$5.86B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.64B
Capital expenditures (TTM)
$483.20M
R&D (TTM)
—
SG&A (TTM)
$2.22B
Stock compensation (TTM)
$125.50M
R&D / revenue
—
Stock compensation / revenue
0.9%

Ownership (13F)

9 metrics
13F filers
1,052
13F filer change QoQ
+27
Institutional ownership
98.2%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
26.7%
Private-fund adviser ownership
26.4%
Active holders' share change QoQ
0.0%
Holder tenure
7.6
Price vs estimated holder cost
+24.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.7%

Short interest

3 metrics
Short interest
3.3%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.17M
Insider-sentiment score
39 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 920148 CUSIP 504922105 13F (30d) 202 filings 184 filers Visit website Investor relations